Patents by Inventor Angela Coxon

Angela Coxon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers and use of MET inhibitor for treatment of cancer
    Patent number: 10328062
    Abstract: The present invention relates to methods of therapeutic treatment of cancer using selective tyrosine kinase inhibitors and cancer biomarkers, such as MET amplification and high Met expression for patient selection.
    Type: Grant
    Filed: April 3, 2015
    Date of Patent: June 25, 2019
    Assignee: Amgen, Inc.
    Inventors: Sean Caenepeel, Angela Coxon, Zhiqiang Du, Paul Hughes, Robert Loberg, Gataree Ngarmchamnanrith, Beate Sable
  • BIOMARKERS AND USE OF MET INHIBITOR FOR TREATMENT OF CANCER
    Publication number: 20170182016
    Abstract: The present invention relates to methods of therapeutic treatment of cancer using selective tyrosine kinase inhibitors and cancer biomarkers, such as MET amplification and high Met expression for patient selection.
    Type: Application
    Filed: April 3, 2015
    Publication date: June 29, 2017
    Inventors: Sean CAENEPEEL, Angela COXON, Zhiqiang DU, Paul HUGHES, Robert LOBERG, Gift NGARMCHAMNANRITH, Beate SABLE
  • COMBINATIONS VEGF(R) INHIBITORS AND HEPATOCYTE GROWTH FACTOR (C-MET) INHIBITORS FOR THE TREATMENT OF CANCER
    Publication number: 20140243339
    Abstract: This invention is in the field of pharmaceutical agents and specifically relates to compounds, compositions, uses and methods for treating cancer, by combining VEGF(R) inhibitors and inhibitors of HGF/SF:c-Met.
    Type: Application
    Filed: February 28, 2014
    Publication date: August 28, 2014
    Applicant: Amgen Inc.
    Inventors: Teresa L. Burgess, Angela Coxon, Isabelle Dussault, Paula Kaplan-Lefko, Anthony J. Polverino, Darrin Beaupre
  • SPECIFIC BINDING AGENTS TO HEPATOCYTE GROWTH FACTOR
    Publication number: 20140154243
    Abstract: Specific binding agents that interact with hepatocyte growth factor (HGF) are described. Methods of treating cancer by administering a pharmaceutically effective amount of a specific binding agent to HGF are described. Methods of detecting the amount of HGF in a sample using a specific binding agent to HGF are described.
    Type: Application
    Filed: November 21, 2013
    Publication date: June 5, 2014
    Applicants: AMGEN FREMONT INC., AMGEN INC.
    Inventors: Teresa L BURGESS, Angela COXON, Larry L GREEN, Ke ZHANG
  • Specific binding agents to hepatocyte growth factor
    Patent number: 8609090
    Abstract: Specific binding agents that interact with hepatocyte growth factor (HGF) are described. Methods of treating cancer by administering a pharmaceutically effective amount of a specific binding agent to HGF are described. Methods of detecting the amount of HGF in a sample using a specific binding agent to HGF are described.
    Type: Grant
    Filed: July 16, 2004
    Date of Patent: December 17, 2013
    Assignees: Amgen Inc., Amgen Fremont Inc.
    Inventors: Teresa L. Burgess, Angela Coxon, Larry L. Green, Ke Zhang
  • COMBINATIONS VEGF(R) INHIBITORS AND HEPATOCYTE GROWTH FACTOR (C-MET) INHIBITORS FOR THE TREATMENT OF CANCER
    Publication number: 20110104161
    Abstract: This invention is in the field of pharmaceutical agents and specifically relates to compounds, compositions, uses and methods for treating cancer, by—combining VEGF(R) inhibitors and inhibitors of HGF/SF:c-Met.
    Type: Application
    Filed: May 14, 2009
    Publication date: May 5, 2011
    Inventors: Teresa L. Burgess, Angela Coxon, Isabelle Dussault, Paula Kaplan-Lefko, Anthony J. Polverino, Darrin Beaupre
  • Specific binding agents to hepatocyte growth factor
    Publication number: 20050118643
    Abstract: Specific binding agents that interact with hepatocyte growth factor (HGF) are described. Methods of treating cancer by administering a pharmaceutically effective amount of a specific binding agent to HGF are described. Methods of detecting the amount of HGF in a sample using a specific binding agent to HGF are described.
    Type: Application
    Filed: July 16, 2004
    Publication date: June 2, 2005
    Inventors: Teresa Burgess, Angela Coxon, Larry Green, Ke Zhang